Alisertib
Aurora Kinase A (AURKA) Inhibitor
- CAS
- 1028486-01-2
- Formula
- C27H20ClFN4O4
- Mol. weight
- 518.93 g/mol
- Purity
- ≥99%
Added. View your enquiry →
Price on request. CoA, HPLC, NMR and SDS available on request. For Research Use Only. Not for human or veterinary use.
Alisertib is a selective Aurora Kinase A inhibitor that disrupts mitotic spindle assembly by preventing AURKA-mediated phosphorylation of TACC3 and other centrosomal substrates, leading to multipolar spindle formation and mitotic exit failure. Shows particular activity in MYC-amplified haematological malignancies and MYCN-amplified neuroblastoma and SCLC.
Target class: Aurora, PLK1 and kinesin inhibitors
Research areas: Breast Cancer, Leukemia, Lung Cancer
Related compounds
| SMILES | COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC |
|---|---|
| InChIKey | ZLHFILGSQDJULK-UHFFFAOYSA-N |
